Article Type : Research Article
Authors : Bjane O, Mehdi I, Tmiri A, Taibou T, Kbiro A, Moataz A, Dakir M, Debbagh A and Aboutaieb R
Keywords : Radical cystectomy, Urinary diversion, Quality of life, SF-36,Barthel index
Introduction:
Radical cystectomy with urinary diversion is the standard treatment for
invasive or high-risk non-invasive bladder cancer. The choice of diversion
depends on clinical, surgical, and functional factors and directly influences
quality of life (QoL). In the elderly population, few studies have compared the
different techniques.
Materials
and Methods: We conducted a prospective study between 2021 and 2024 in the
urology department of the University Hospital of Casablanca. A total of 99
patients underwent radical cystectomy, of whom 83 completed the SF-36 and
Barthel index questionnaires. Two groups were compared: ileal conduit (IC,
n=32) and ureterocutaneostomy (UC, n=51). Clinical, operative, and
postoperative data were analyzed.
Results:
The mean follow-up was longer for patients with ileal conduit than for those
with ureterocutaneostomy. UC was associated with shorter operative time and
hospital stay, as well as earlier drain removal. Regarding QoL, the ileal
conduit was associated with better emotional function, while UC was correlated
with more marked fatigue. No significant difference was observed for the other
dimensions of QoL between the two groups.
Discussion:
These results confirm that the choice of diversion must be individualized. The
ileal conduit appears to be a more suitable option for younger patients in good
general condition who are concerned about their body image and psychological
well-being. Ureterocutaneostomy remains a safer alternative in elderly and
frail patients due to its reduced operative risk.
Conclusion:
Although no overall difference in QoL was observed, the ileal conduit seems
preferable for young and fit patients, while UC should be favored in high-risk
elderly patients. The use of QoL questionnaires and informed counseling remain
essential to guide therapeutic decision-making.
Radical
cystectomy with urinary diversion remains the standard of care for
muscle-invasive bladder cancer and for high-risk non-muscle-invasive tumors
refractory to conservative treatments [1]. Despite significant advances in
surgical techniques and perioperative management, this procedure continues to
be associated with substantial morbidity and has a profound impact on patients'
quality of life [2]. The selection of the optimal urinary diversion type
following radical cystectomy is a critical decision that requires careful
individualization. This choice depends on a range of factors, including patient
age, comorbidities, functional status, renal function, life expectancy,
personal preferences, and surgical expertise [3]. The primary options: ileal
conduit, and cutaneous ureterostomy—each present a distinct profile in terms of
technical complexity, perioperative morbidity, functional outcomes, and
psychosocial adaptation. Beyond achieving oncological control, the evaluation
of patient-reported outcomes and health-related quality of life (HRQoL) has
become central to the therapeutic decision-making process [4]. Particularly in
elderly or frail populations, maintaining functional autonomy and a
satisfactory quality of life are essential treatment objectives [5]. However,
the available comparative data regarding the impact of different urinary
diversion techniques on quality of life remain heterogeneous and sometimes
conflicting [6]. Consequently, a more precise characterization of postoperative
functional outcomes and patient autonomy is necessary to optimize patient
selection and enhance the personalization of care. In this context, the present
study aims to compare the perioperative outcomes and quality-of-life impact of
different urinary diversion techniques using validated functional and
quality-of-life assessment tools. The goal is to provide objective evidence to
inform and refine the clinical decision-making process. Here is a high-level,
optimized English translation of the "Materials and Methods" section,
suitable for submission to an international scientific journal.
Study Design and Patient Selection
A single-center cross-sectional study was conducted in the Urology Department of the University Hospital of Casablanca. Informed consent was obtained from all participants. Data were retrospectively collected from the medical records of patients who underwent radical cystectomy (RC) with urinary diversion between 2021 and 2025. Quality of life questionnaires were administered during follow-up consultations or via standardized telephone interviews. The analyzed variables included: age, sex, body mass index (BMI), operative time, length of hospital stay, time to drain removal, variations in hemoglobin and creatinine levels, postoperative complications, and follow-up duration. Patients were stratified into three groups according to the type of urinary diversion: orthotopic neobladder, ileal conduit (IC), and cutaneous ureterostomy (CU). The SF-36 and Barthel Index questionnaires were administered to all surviving patients with ongoing follow-up. Exclusion criteria were: death from non-oncological causes within the first three postoperative months, absence of follow-up data, local recurrence or metastatic disease, and presence of a concomitant cancer. Cutaneous ureterostomy was preferentially indicated in patients presenting with positive lymph nodes, positive urethral margins, limited life expectancy, severe neurological or psychiatric comorbidities, significant hepatic or renal impairment, history of high-dose pelvic radiotherapy, complex urethral stricture, severe incontinence, inflammatory bowel disease, or in cases of salvage cystectomy
All cystectomies were performed using an open approach according to standard techniques. For ileal conduit, a 15 cm ileal segment was isolated approximately 20 cm proximal to the ileocecal valve. The ureters were spatulated and anastomosed using either the Wallace or Bricker technique. For cutaneous ureterostomy, a V-shaped or U-shaped skin flap was fashioned, the ureter was extraperitoneal zed, and a double-J stent was placed prior to skin closure with 4-0 polyglactin sutures.
Follow-up Data Collection and Functional Assessment
Among the operated patients (40 IC, 59 CU), complete quality of life data was obtained for 32 IC patients and 51 CU patients. Health-related quality of life was assessed using the validated SF-36 questionnaire, which evaluates eight dimensions: physical functioning, role limitations due to physical health, role limitations due to emotional problems, vitality, mental health, social functioning, bodily pain, and general health perception. Each domain is scored from 0 (maximal impairment) to 100 (optimal status). Functional autonomy was evaluated using the Barthel Index (BI), which measures independence in activities of daily living (feeding, grooming, dressing, mobility, transfers, stair climbing). The total score ranges from 0 (complete dependence) to 100 (complete independence). Here is the optimized English translation of the "Results" section, with the corrected specific postoperative events as requested.
Demographic
and Perioperative Data
Demographic
and perioperative characteristics were compared across the three urinary
diversion groups in 99 patients. No significant differences were observed
regarding mean age, sex distribution, body mass index (BMI), or perioperative
hemoglobin variations. Operative time differed significantly between groups (p
< 0.001), being shortest in the cutaneous ureterostomy (CU) group and
longest in the ileal conduit (IC) group. Length of hospital stay was
significantly shorter in the CU group compared to the IC group (p = 0.002).
Similarly, time to drain removal and follow-up duration were significantly
shorter in the CU group than in the IC group (p = 0.002 and p < 0.001,
respectively). Pre- and postoperative creatinine level variations are presented
in (Table 1).
Quality of Life and Functional
Autonomy
Among
the 83 patients who completed the quality-of-life questionnaires, only the
"emotional function" and "fatigue" dimensions of the SF-36
differed significantly between groups (p = 0.016 and p = 0.001, respectively). The IC group exhibited
significantly higher emotional function scores, while the CU group reported
higher fatigue scores. No
significant association was observed between the occurrence of complications
and quality of life or autonomy scale scores.
Complications and Associated
Factors
A
significant association was found between the occurrence of complications and
both length of hospital stays and ASA score. The presence of complications was
correlated with a significant prolongation of hospitalization, while an ASA
score of 4 increased the risk of complications. A significant relationship was
also observed between complication occurrence and follow-up duration: patients
who experienced complications had a shorter follow-up period. Multivariate
analysis identified age and ASA score as independent factors associated with
complications. A one-year decrease in age was associated with an increased risk
of complications (OR = 1.11; 95% CI: 1.02–1.21). An ASA score of 4 was
associated with a major increase in complication risk compared to scores 2–3
(OR = 31.98; 95% CI: 3.97–257.64) (Table 2).
Table 1: Preoperative and postoperative blood creatinine levels of the patient groups.
|
Creatinine |
Preop |
Postop |
Postop 1st month |
Postop 3rd month |
|
Ureterocutaneostomy |
1,28 ± 0,93 1,09 (0,9–1,31) |
1,30 ± 0,80 1,17 (0,95–1,4) |
1,34 ± 0,90 1,11 (0,89–1,41) |
1,38 ± 1,24 1,13 (0,92–1,53) |
|
Orthotopic Neobladder |
1,06 ± 0,37 0,91 (0,79–1,38) |
1,23 ± 0,55 1,12 (0,95–1,39) |
1,2 ± 0,37 1,26 (0,9–1,5) |
1,23 ± 0,48 1,19 (0,84–1,54) |
Table 2: Comparison of the characteristics and perioperative outcomes of patient groups.
|
Groups |
Ureterocutaneostomy |
Ileal Conduit |
|
Age, Mean ± SD |
68,0 ± 9,5 |
68,4 ± 8,7 |
|
Gender,n,(%) |
|
|
|
Male |
46 (%90) |
32 (%100) |
|
Female |
5 (%10) |
0 (%0) |
|
BMI, Mean ± SD |
25 ± 2,8 |
25,1 ± 3,5 |
|
Operation Time (minute)Mean ± SD |
262,7 ± 77,9 |
316,5 ± 72,4 |
|
Hospital stay (day) Mean ± SD |
11,3 ± 9,4 |
13,6 ± 11,8 |
|
median (IQR |
8 (6–16) |
10 (8–15) |
|
Hgb change, mean ± SD |
3,1 ± 1,3 |
3,3 ± 1,3 |
|
Drain withdrawal time (day), |
|
|
|
Mean ± SD Median (IQR) |
5,7 ± 2,3 5 (4–7) |
7 ± 2,8 7 (5–8) |
|
Follow-up time, |
|
|
|
mean ± SD median (IQR) |
11,7 ± 13,5 6 (1–56) |
24,2 ± 20,8 19 (0–72) |
|
Creatinine preop, |
|
|
|
mean ± SD |
1,28 ± 0,93 |
1,05 ± 0,35 |
|
median (IQR) |
1,09 (0,9–1,31) |
0,96 (0,82–1,21) |
|
Creatinine postop, |
|
|
|
mean ± SD |
1,30 ± 0,80 |
1,14 ± 0,35 |
|
Median (IQR) |
1,17 (0,95–1,4) |
1,09 (0,9–1,33) |
|
Creatinine postop1 st month, |
|
|
|
Mean ± SD |
1,34 ± 0,90 |
1,30 ± 0,72 |
|
median (IQR) |
1,11 (0,89–1,41) |
1,09 (0,85–1,58) |
|
Creatinine postop 3rd month, |
|
|
|
Mean ± SD |
1,38 ± 1,24 |
1,41 ± 0,72 |
|
Median (IQR) |
1,13 (0,92–1,53) |
1,3 (1–1,49) |
Mortality and Prognostic Factors
Mortality was significantly associated with operative time, preoperative hemoglobin level, and Charlson Comorbidity Index (CCI). Deceased patients had shorter operative times, lower preoperative hemoglobin, and higher CCI scores. A significant association was also observed between mortality and follow-up duration, as well as pre- and postoperative creatinine levels. Deceased patients had shorter follow-up durations and consistently higher creatinine values. On multivariate analysis, CCI score and preoperative hemoglobin emerged as independent factors for mortality. A one-point increase in CCI was associated with an increased risk of mortality (OR = 1.84; 95% CI: 1.31–2.58). A one-unit decrease in preoperative hemoglobin increased the risk of mortality (OR = 1.32; 95% CI: 1.04–1.67). Although statistically significant differences in preoperative albumin levels were observed between the CU and IC groups, these remained within normal limits and were not considered clinically relevant.
Specific Postoperative Events
Two patients required ileal resection, and two required colostomies, with subsequent survival (Table 3).
Table 3: Comparison of perioperative outcomes based on complications and mortality.
|
|
Complication |
|
Mortality |
|
|
No |
Yes |
Alive |
Ex |
|
|
Group, n (%)* |
|
|
|
|
|
Ureterocutaneostomy |
46 (%90) |
5 (%10) |
47 (%92) |
4 (%8) |
|
Ileal conduit |
31 (%98) |
1 (%2) |
30 (%94) |
2 (%6) |
|
Age Mean ± SD |
68,1 ± 9,0 |
62,4 ± 7,7 |
67,2 ± 8,6 |
68,9 ± 9,9 |
|
Gender,n,(%)* |
|
|
|
|
|
Male |
71 (%85) |
5 (%6) |
70 (%84) |
6 (%7) |
|
Female |
6 (%7) |
1 (%1) |
7(%8) |
0(%0) |
|
BMI, Mean ± SD |
25,2 ± 3,1 |
25,1 ± 4,4 |
25,3 ± 3,1 |
24,9 ± 3,2 |
|
Operation Time (minute)Mean ± SD |
307,8 ± 94,1 |
283,1 ± 78,3 |
318,1 ± 91,3 |
283,4 ± 93,7 |
|
Hospital stay (day),
Mean ± SD median (IQR |
12,5 ± 10,5 9 (7–14) |
23,9 ± 18,1 16,5 (11,5–37) |
12,9 ± 11,4 10 (7–14,5) |
13,5 ± 11,1 10 (7–16) |
|
Preoperative Hgb, Mean
± SD |
12,2 ± 1,8 |
11,3 ± 1,6 |
12,5 ± 1,8 |
11,5 ± 1,6 |
|
Preoperative Albumin, Mean
± SD |
35,6 ± 5,7 |
34,9 ± 6,0 |
36,1 ± 5,1 |
34,7 ± 6,7 |
|
ASA score, n (%) * |
|
|
|
|
|
2 |
47 (%98) |
1 (%2) |
32 (%67) |
16 (%33) |
|
3 |
79 (%95) |
4 (%5) |
55 (%66) |
28 (%34) |
|
4 |
4 (%57) |
3 (%43) |
5 (%71) |
2 (%29) |
|
CCI, Mean ± SD |
4,98 ± 1,37 |
5,75 ± 1,39 |
4,66 ± 1,32 |
5,72 ± 1,23 |
|
Median (IQR) |
5 (4–8) |
6 (4,5–6,5) |
4 (4–6) |
6 (5–6) |
|
Hgb change, Mean ± SD |
3,28 ± 1,29 |
3,49 ± 1,11 |
3,3 ± 1,29 |
3,27 ± 1,26 |
|
Drain withdrawal time (day), Mean ± SD |
6,75 ± 4,1 |
8,88 ± 3,87 |
7,1 ± 4,6 |
6,4 ± 2,8 |
|
Median (IQR |
6 (2–38) |
7 (5–15) |
7 (5–8) |
5 (4–8) |
|
Follow-up time, mean
± SD |
20,8 ± 20,3 |
6,4 ± 6,1 |
22,6 ± 21,1 |
14,9 ± 16,8 |
|
median (IQR) |
13 (4–31) |
4,5 (2–9) |
16 (6–35) |
11 (2–18) |
|
Creatinine preop, mean ± SD |
1,15 ± 0,68 |
1,15 ± 0,32 |
1,07 ± 0,41 |
1,31 ± 0,99 |
|
median (IQR) |
1,01 (0,86–1,28) |
1,17 (0,94–1,4) |
0,98 (0,81–1,21) |
1,09 (0,91–1,44) |
|
Creatinine postop, mean
± SD |
1,21 ± 0,61 |
1,28 ± 0,44 |
1,14 ± 0,42 |
1,38 ± 0,84 |
|
Median (IQR) |
1,12 (0,92–1,37) |
1,25 (1,11–1,31) |
1,09 (0,84–1,38) |
1,2 (1,05–1,34) |
|
Creatinine postop1 st month, |
|
|
|
|
|
Mean ± SD |
1,31 ± 0,78 |
1,20 ± 0,51 |
1,24 ± 0,79 |
1,45 ± 0,72 |
|
median (IQR) |
1,1 (0,88–1,52) |
1,1 (0,8–1,37) |
1,05 (0,78–1,49) |
1,25 (1,01–1,59) |
|
Creatinine |
|
|
|
|
|
postop 3rd month, Mean ± SD |
1,39 ± 0,95 |
1,16 ± 0,56 |
1,28 ± 0,95 |
1,59 ± 0,86 |
|
Median (IQR) |
1,21 (0,95–1,53) |
1 (0,85–1,15) |
1,15 (0,9–1,4) |
1,35 (1,07–1,7) |
The choice of urinary diversion type after radical cystectomy is based on an individualized assessment integrating patient preferences, functional status, life expectancy, and oncologic control. In clinical practice, ileal conduit (IC) represents the most frequently used option [7]. Ileal conduit is generally associated with better body image perception and improved social interactions, but it remains technically more demanding and may be associated with a higher reoperation rate [8]. Cutaneous ureterostomy (CU), the simplest technique, constitutes a relevant alternative in frail patients (ASA score ? 3), as it avoids the use of an intestinal segment, thereby reducing metabolic and surgical complications. It is particularly indicated in patients requiring anticoagulation, presenting with inflammatory bowel disease, or with a history of multiple abdominal surgeries [1,9]. Regarding morbidity, Kilciler et al. reported no increased risk of complications or reoperation with CU compared to IC, suggesting that CU constitutes a safe alternative [13]. However, other studies have reported divergent results [14,15], highlighting the heterogeneity of study populations and selection criteria. Concerning blood loss, our results show comparable hemoglobin variations between groups (p = 0.128), in agreement with the work of Kilciler and Sainin [1,13], as well as with Moeen et al., who found no significant difference in transfusion requirements between continent and incontinent diversions [2]. Experience in a high-volume center may contribute to reduced transfusion requirements. Preservation of renal function is a major concern. Some studies suggest an increased risk of renal impairment after CU due to recurrent pyelonephritis episodes or hydronephrosis secondary to stomal stenosis [1,9]. However, a comparative study including four types of diversion showed no significant difference in terms of renal function, although recurrent pyelonephritis and chemotherapy may play a deleterious role [16]. In our cohort, the increase in creatinine was significant in the IC group (p = 0.004), while the variations observed in the CU groups were more moderate. These results could be explained by direct and continuous urinary drainage in CU, whereas the ileal conduit may be exposed to reflux phenomena, anastomotic stenosis, or reservoir dysfunction. Quality of life after urinary diversion depends on multiple factors, including age, comorbidities, type of diversion, occurrence of complications, patient expectations, and surgical expertise. It is recommended that these procedures be performed in high-volume centers [2].
Few
studies have simultaneously compared both modalities (CU, IC) [2,17,18]. In our
study, assessment was based on the SF-36 [3] and Barthel index [4]
questionnaires, which constitutes an original approach in this population.
Literature data are contrasting. Erber et al., using the EORTC QLQ-C30 and
BLM30 questionnaires, reported an advantage of IC in terms of physical function
and global health status [19-20]. Other work suggests that IC might offer
benefits in elderly patients on certain functional parameters, provided there
are no long-term complications [21]. Conversely, Elbadry et al., using the
FACT-BL questionnaire, observed higher overall scores in IC patients associated
with better body image and better urinary control [22]. A meta-analysis of 21 studies
including 2,285 patients showed globally comparable results, with a slight
advantage for IC in young patients in good general condition [23]. In our
study, only the "emotional function" and "fatigue"
dimensions differed significantly. IC patients presented better emotional
scores, probably related to more favorable body perception. In contrast, CU
patients reported more fatigue, possibly related to initial frailty,
comorbidities, and constraints associated with stoma equipment, particularly at
night. These findings are consistent with the observations of Thulin et al.,
who reported impaired sleep and quality of life in some IC patients due to
incontinence [24], highlighting the multifactorial complexity of these
assessments. Some studies suggest that neither age, nor postoperative
complications, nor BMI significantly influence long-term quality of life [25].
Our results confirm that, despite some specific differences, overall quality of
life scores remain comparable between modalities. However, our study has
several limitations: relatively short follow-up duration, single-center design,
limited sample size in the IC group, and incomplete questionnaire response
rate. Furthermore, assessments were performed at different postoperative time
points, which may introduce variability. In conclusion, although many
quality-of-life dimensions are similar between the two techniques, ileal
conduit appears associated with better emotional function, while cutaneous
ureterostomy is associated with more pronounced fatigue. IC seems more suitable
for young patients in good general condition, whereas CU constitutes a relevant
option for elderly high-risk patients. The decision must remain individualized,
integrating comorbidities, surgeon experience, and detailed patient information,
with quality-of-life questionnaires serving as an essential decision-making aid
tool.